MedTrace Logo

A Study Regarding Tissue Response During and After Treatment for Anal Cancer

NCT05939401 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-03-18

No results posted yet for this study

Summary

The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining:

* The tumour microenvironment
* The localisation of and cellular interactions between the tumour and immune cells
* The gene and protein expression by cells present in the tumour and surrounding tissue.

Conditions

Interventions

OTHER

Biopsies

Biopsies and blood samples will be taken at time of diagnosis or recurrence

Sponsors & Collaborators

  • Göteborg University

    collaborator OTHER

  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2027-12-01
Completion
2029-12-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05939401 on ClinicalTrials.gov